NASDAQ · SIBN
SI-BONE, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for SIBN: Nov 02, 2026
SI-BONE, Inc. Common Stock is expected to report earnings on 11/02/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.13. The reported EPS for the same quarter last year was $-0.11.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.13 | $-0.12 | $-0.13 | 2 |
| Dec 2026 | $-0.11 | $-0.11 | $-0.11 | 1 |
| Mar 2027 | $-0.11 | $-0.11 | $-0.11 | 1 |
| Jun 2027 | $-0.10 | $-0.10 | $-0.10 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Zacks · The Motley Fool · MarketBeat- RTTNews · Oct 2, 12:13 PM EDTWeekly Buzz: EW, ABBV, MIRM Score FDA Wins, AZN, NVO Strike Deals; LLY, KOD Report Data(RTTNews) – The week brought a fresh round of developments across the biotech and pharma landscape, with companies advancing new therapies through regulatory milestones, clinical studies, strategic deals and corporate activity. Key updates spanned oncology, rare diseases, cardiov
- RTTNews · Sep 29, 1:43 AM EDTSI-BONE Gets FDA 510(k) Clearance For IFuse Granite Onyx In Spinal Fusion(RTTNews) – SI-BONE, Inc. (SIBN) announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its iFuse Granite Onyx System (Onyx), expanding the company's compromised bone franchise beyond the pelvis.
- Zacks · Aug 25, 12:00 PM EDTSi-Bone (SIBN) is a Great Momentum Stock: Should You Buy?Does Si-Bone (SIBN) have what it takes to be a top stock pick for momentum investors? Let's find out.
- Zacks · Aug 24, 9:55 AM EDTWall Street Analysts Believe Si-Bone (SIBN) Could Rally 25.25%: Here's is How to TradeThe mean of analysts' price targets for Si-Bone (SIBN) points to a 25.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
- The Motley Fool · Aug 10, 9:29 PM EDTSI-BONE (SIBN) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Aug 6, 9:55 AM EDTDoes Si-Bone (SIBN) Have the Potential to Rally 38.58% as Wall Street Analysts Expect?The consensus price target hints at a 38.6% upside potential for Si-Bone (SIBN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- RTTNews · Aug 4, 1:20 AM EDTSI-BONE Q2 Net Loss Narrows On Revenue Growth; Raises Lower End Of 2026 Revenue Guidance(RTTNews) – SI-BONE, Inc. (SIBN) on Tuesday reported financial results for the second quarter of 2026, reflecting a narrowed net loss backed by revenue growth. In addition, the company has updated revenue guidance for the full year 2026.
- Zacks · Aug 3, 6:45 PM EDTSi-Bone (SIBN) Reports Q2 Loss, Tops Revenue EstimatesSi-Bone (SIBN) delivered earnings and revenue surprises of +40.00% and +1.98%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- MarketBeat · Aug 3, 6:03 PM EDTSiBone Q2 Earnings Call Highlights4 Recent Earnings Winners Riding Fresh Momentum in MaySiBone (NASDAQ:SIBN) reported second-quarter 2026 revenue growth of 15.2% and narrowed its net loss as procedure volumes increased across its U.S. business and international demand rose for its expanded product portfolio. Wor
- Zacks · Jun 3, 9:55 AM EDTBears are Losing Control Over Si-Bone (SIBN), Here's Why It's a 'Buy' NowSi-Bone (SIBN) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
- Zacks · Jun 1, 9:55 AM EDTWall Street Analysts Predict a 71.13% Upside in Si-Bone (SIBN): Here's What You Should KnowThe average of price targets set by Wall Street analysts indicates a potential upside of 71.1% in Si-Bone (SIBN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- Zacks · May 15, 9:55 AM EDTHow Much Upside is Left in Si-Bone (SIBN)? Wall Street Analysts Think 65.27%The consensus price target hints at a 65.3% upside potential for Si-Bone (SIBN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for SI-BONE, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.